Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Time to diagnosis of tuberculosis is greater in older patients: a retrospective cohort review.

Abbara A, Collin SM, Kon OM, Buell K, Sullivan A, Barrett J, Corrah T, McGregor A, Hansel T, John L, Davidson RN.

ERJ Open Res. 2019 Nov 4;5(4). pii: 00228-2018. doi: 10.1183/23120541.00228-2018. eCollection 2019 Oct.

2.

Screening contacts of patients with extrapulmonary TB for latent TB infection.

Humphreys A, Abbara A, Williams S, John L, Corrah T, McGregor A, Davidson RN.

Thorax. 2018 Mar;73(3):277-278. doi: 10.1136/thoraxjnl-2016-209639. Epub 2017 May 11.

PMID:
28495787
3.

Complications of miliary tuberculosis: low mortality and predictive biomarkers from a UK cohort.

Underwood J, Cresswell F, Salam AP, Keeley AJ, Cleland C, John L, Davidson RN.

BMC Infect Dis. 2017 Apr 20;17(1):295. doi: 10.1186/s12879-017-2397-6.

4.

Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK.

Abbara A, Chitty S, Roe JK, Ghani R, Collin SM, Ritchie A, Kon OM, Dzvova J, Davidson H, Edwards TE, Hateley C, Routledge M, Buckley J, Davidson RN, John L.

BMC Infect Dis. 2017 Mar 24;17(1):231. doi: 10.1186/s12879-017-2330-z.

5.

Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.

Rawson TM, Abbara A, Kranzer K, Ritchie A, Milburn J, Brown T, Adeboyeku D, Buckley J, Davidson RN, Berry M, Kon OM, John L.

Respir Med. 2016 Nov;120:101-108. doi: 10.1016/j.rmed.2016.10.001. Epub 2016 Oct 6.

6.

Time to detection in liquid culture of sputum in pulmonary MDR-TB does not predict culture conversion for early discharge.

Rieu R, Chang C, Collin SM, Fazekas J, Dassanaike S, Abbara A, Davidson RN.

J Antimicrob Chemother. 2016 Mar;71(3):803-6. doi: 10.1093/jac/dkv407. Epub 2015 Dec 11.

PMID:
26661394
7.

False-positive Xpert(®) MTB/RIF more than seven years after cure.

Stevenson DR, Biswas JR, Lievesley A, Quinn G, Buckley J, John L, Davidson RN.

Int J Tuberc Lung Dis. 2015 Oct;19(10):1264-5. doi: 10.5588/ijtld.15.0419. No abstract available.

PMID:
26459550
8.

Whole spine imaging is justified in tuberculous spondylodiscitis but not pyogenic spondylodiscitis.

Abbara A, Tivey A, John L, Davidson RN.

J Infect. 2016 Jan;72(1):125-6. doi: 10.1016/j.jinf.2015.09.034. Epub 2015 Oct 9. No abstract available.

PMID:
26433142
9.

Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis.

Gow NJ, Davidson RN, Ticehurst R, Burns A, Thomas MG.

PLoS Negl Trop Dis. 2015 Aug 25;9(8):e0003983. doi: 10.1371/journal.pntd.0003983. eCollection 2015.

10.

Filiform Polyposis Secondary to Colonic Tuberculosis Presenting as Acute Colo-Colonic Intussusception.

Heng JS, Baird A, Novelli MR, Davidson RN, Bhutiani RP.

Case Rep Surg. 2015;2015:578263. doi: 10.1155/2015/578263. Epub 2015 May 31.

11.

Recurrent tuberculosis at a large tuberculosis centre in the UK.

Avery K, Abbara A, Ghani R, Davidson RN.

J Infect. 2015 Apr;70(4):427-9. doi: 10.1016/j.jinf.2014.11.011. Epub 2014 Dec 4. No abstract available.

PMID:
25481404
12.

Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal Leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh-a case report.

Marking U, den Boer M, Das AK, Ahmed EM, Rollason V, Ahmed BN, Davidson RN, Ritmeijer K.

PLoS Negl Trop Dis. 2014 Jun 12;8(6):e2864. doi: 10.1371/journal.pntd.0002864. eCollection 2014 Jun. No abstract available.

13.

Reversing the tide of the UK tuberculosis epidemic.

Shah N, Young S, Ghani R, John L, Davidson RN.

Lancet. 2014 Jan 18;383(9913):215. doi: 10.1016/S0140-6736(14)60068-4. No abstract available.

PMID:
24439734
14.

Ethnic variation in inflammatory profile in tuberculosis.

Coussens AK, Wilkinson RJ, Nikolayevskyy V, Elkington PT, Hanifa Y, Islam K, Timms PM, Bothamley GH, Claxton AP, Packe GE, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Drobniewski FA, Mein CA, Bhaw-Rosun L, Nuamah RA, Griffiths CJ, Martineau AR.

PLoS Pathog. 2013;9(7):e1003468. doi: 10.1371/journal.ppat.1003468. Epub 2013 Jul 4.

15.

Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre.

Eder M, Farne H, Cargill T, Abbara A, Davidson RN.

Pathog Glob Health. 2012 Jul;106(3):181-7. doi: 10.1179/2047773212Y.0000000032.

16.

Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment.

Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, Timms PM, Venton TR, Bothamley GH, Packe GE, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Mein CA, Bhaw-Rosun L, Nuamah R, Young DB, Drobniewski FA, Griffiths CJ, Martineau AR.

Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15449-54. Epub 2012 Sep 4.

17.

Extra-pulmonary tuberculosis developing at sites of previous trauma.

Barr DA, Whittington AM, White B, Patterson B, Davidson RN.

J Infect. 2013 Apr;66(4):313-9. doi: 10.1016/j.jinf.2012.08.010. Epub 2012 Aug 27.

PMID:
22935576
18.

Diagnosis and treatment strategies of tuberculous intestinal perforations: a case series.

Lee MJ, Cresswell FV, John L, Davidson RN.

Eur J Gastroenterol Hepatol. 2012 May;24(5):594-9. doi: 10.1097/MEG.0b013e328350fd4a.

PMID:
22293329
19.

Etiology and management of genitourinary tuberculosis.

Abbara A, Davidson RN; Medscape.

Nat Rev Urol. 2011 Dec 9;8(12):678-88. doi: 10.1038/nrurol.2011.172. Review.

PMID:
22157940
20.

Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence.

Ritmeijer K, ter Horst R, Chane S, Aderie EM, Piening T, Collin SM, Davidson RN.

Clin Infect Dis. 2011 Dec;53(12):e152-8. doi: 10.1093/cid/cir674. Epub 2011 Oct 19.

PMID:
22016502
21.

High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.

Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, Packe GE, Moore-Gillon JC, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Woodward NJ, Venton TR, Barnes KE, Mullett CJ, Coussens AK, Rutterford CM, Mein CA, Davies GR, Wilkinson RJ, Nikolayevskyy V, Drobniewski FA, Eldridge SM, Griffiths CJ.

Lancet. 2011 Jan 15;377(9761):242-50. doi: 10.1016/S0140-6736(10)61889-2. Epub 2011 Jan 5.

22.

Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends.

Gorski S, Collin SM, Ritmeijer K, Keus K, Gatluak F, Mueller M, Davidson RN.

PLoS Negl Trop Dis. 2010 Jun 8;4(6):e705. doi: 10.1371/journal.pntd.0000705.

23.

Association between Gc genotype and susceptibility to TB is dependent on vitamin D status.

Martineau AR, Leandro AC, Anderson ST, Newton SM, Wilkinson KA, Nicol MP, Pienaar SM, Skolimowska KH, Rocha MA, Rolla VC, Levin M, Davidson RN, Bremner SA, Griffiths CJ, Eley BS, Bonecini-Almeida MG, Wilkinson RJ.

Eur Respir J. 2010 May;35(5):1106-12. doi: 10.1183/09031936.00087009. Epub 2009 Sep 24.

24.

Frequencies of region of difference 1 antigen-specific but not purified protein derivative-specific gamma interferon-secreting T cells correlate with the presence of tuberculosis disease but do not distinguish recent from remote latent infections.

Hinks TS, Dosanjh DP, Innes JA, Pasvol G, Hackforth S, Varia H, Millington KA, Liu XQ, Bakir M, Soysal A, Davidson RN, Gunatheesan R, Lalvani A.

Infect Immun. 2009 Dec;77(12):5486-95. doi: 10.1128/IAI.01436-08. Epub 2009 Sep 14.

25.

Developments in the treatment of visceral leishmaniasis.

den Boer ML, Alvar J, Davidson RN, Ritmeijer K, Balasegaram M.

Expert Opin Emerg Drugs. 2009 Sep;14(3):395-410. doi: 10.1517/14728210903153862. Review.

PMID:
19708817
26.
27.

Miltefosine to treat cutaneous leishmaniasis caused by Leishmania tropica.

Killingley B, Lamb LE, Davidson RN.

Ann Trop Med Parasitol. 2009 Mar;103(2):171-5. doi: 10.1179/136485909X398177. No abstract available.

PMID:
19208301
28.

1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection.

Coussens A, Timms PM, Boucher BJ, Venton TR, Ashcroft AT, Skolimowska KH, Newton SM, Wilkinson KA, Davidson RN, Griffiths CJ, Wilkinson RJ, Martineau AR.

Immunology. 2009 Aug;127(4):539-48. doi: 10.1111/j.1365-2567.2008.03024.x. Epub 2008 Dec 18.

29.

Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients.

Martineau AR, Nanzer AM, Satkunam KR, Packe GE, Rainbow SJ, Maunsell ZJ, Timms PM, Venton TR, Eldridge SM, Davidson RN, Wilkinson RJ, Griffiths CJ.

Int J Tuberc Lung Dis. 2009 Jan;13(1):119-25.

PMID:
19105889
30.

Paromomycin.

Davidson RN, den Boer M, Ritmeijer K.

Trans R Soc Trop Med Hyg. 2009 Jul;103(7):653-60. doi: 10.1016/j.trstmh.2008.09.008. Epub 2008 Oct 23. Review.

PMID:
18947845
31.

Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study.

O'Riordan P, Schwab U, Logan S, Cooke G, Wilkinson RJ, Davidson RN, Bassett P, Wall R, Pasvol G, Flanagan KL.

PLoS One. 2008 Sep 9;3(9):e3173. doi: 10.1371/journal.pone.0003173.

32.

Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.

ter Horst R, Collin SM, Ritmeijer K, Bogale A, Davidson RN.

Clin Infect Dis. 2008 Jun 1;46(11):1702-9. doi: 10.1086/587899.

PMID:
18419422
33.
34.

Neutrophil-mediated innate immune resistance to mycobacteria.

Martineau AR, Newton SM, Wilkinson KA, Kampmann B, Hall BM, Nawroly N, Packe GE, Davidson RN, Griffiths CJ, Wilkinson RJ.

J Clin Invest. 2007 Jul;117(7):1988-94.

35.

IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37.

Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, Skolimowska K, Davidson RN, Sørensen OE, Kampmann B, Griffiths CJ, Wilkinson RJ.

J Immunol. 2007 Jun 1;178(11):7190-8. Erratum in: J Immunol. 2007 Dec 15;179(12):8569-70.

36.

Prospective study of sputum induction, gastric washing, and bronchoalveolar lavage for the diagnosis of pulmonary tuberculosis in patients who are unable to expectorate.

Brown M, Varia H, Bassett P, Davidson RN, Wall R, Pasvol G.

Clin Infect Dis. 2007 Jun 1;44(11):1415-20. Epub 2007 Apr 20.

PMID:
17479935
37.

A single dose of vitamin D enhances immunity to mycobacteria.

Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM, Packe GE, Davidson RN, Eldridge SM, Maunsell ZJ, Rainbow SJ, Berry JL, Griffiths CJ.

Am J Respir Crit Care Med. 2007 Jul 15;176(2):208-13. Epub 2007 Apr 26.

PMID:
17463418
38.

First case of typical Old World cutaneous leishmaniasis treated with miltefosine.

Stojkovic M, Junghanss T, Krause E, Davidson RN.

Int J Dermatol. 2007 Apr;46(4):385-7.

PMID:
17442078
39.

Evaluation of a mass distribution programme for fine-mesh impregnated bednets against visceral leishmaniasis in eastern Sudan.

Ritmeijer K, Davies C, van Zorge R, Wang SJ, Schorscher J, Dongu'du SI, Davidson RN.

Trop Med Int Health. 2007 Mar;12(3):404-14.

40.

Liposomal amphotericin B for the treatment of visceral leishmaniasis.

Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L, Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J.

Clin Infect Dis. 2006 Oct 1;43(7):917-24. Epub 2006 Aug 28.

PMID:
16941377
41.
42.

A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection.

Ritmeijer K, Dejenie A, Assefa Y, Hundie TB, Mesure J, Boots G, den Boer M, Davidson RN.

Clin Infect Dis. 2006 Aug 1;43(3):357-64. Epub 2006 Jun 20.

PMID:
16804852
43.

Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring during antiretroviral therapy.

Belay AD, Asafa Y, Mesure J, Davidson RN.

Ann Trop Med Parasitol. 2006 Apr;100(3):223-7.

PMID:
16630379
44.

Treatment options for visceral leishmaniasis.

den Boer M, Davidson RN.

Expert Rev Anti Infect Ther. 2006 Apr;4(2):187-97. Review.

PMID:
16597201
45.

Unseen Kala-azar deaths in south Sudan (1999-2002).

Collin SM, Coleman PG, Ritmeijer K, Davidson RN.

Trop Med Int Health. 2006 Apr;11(4):509-12.

46.

Evaluation of a new recombinant K39 rapid diagnostic test for Sudanese visceral leishmaniasis.

Ritmeijer K, Melaku Y, Mueller M, Kipngetich S, O'keeffe C, Davidson RN.

Am J Trop Med Hyg. 2006 Jan;74(1):76-80.

PMID:
16407349
47.

Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens.

Wilkinson KA, Kon OM, Newton SM, Meintjes G, Davidson RN, Pasvol G, Wilkinson RJ.

J Infect Dis. 2006 Feb 1;193(3):354-9. Epub 2005 Dec 29.

PMID:
16388482
48.

Teicoplanin-induced vasculitis with cutaneous and renal involvement.

Logan SA, Brown M, Davidson RN.

J Infect. 2005 Oct;51(3):e185-6.

PMID:
16230204
50.

Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis.

Brown M, Noursadeghi M, Boyle J, Davidson RN.

Br J Dermatol. 2005 Jul;153(1):203-5.

PMID:
16029352

Supplemental Content

Loading ...
Support Center